A significant workshop on deep learning and big data is set to take place on April 8 and 9 at the Downtown Library Complex, Room 104. This event aims to equip participants with essential skills in machine learning, addressing the pressing needs of the pharmaceutical industry.
Recent reports indicate that the global average cost of Phase 3 development programs has now exceeded $1.2 billion. This staggering figure highlights the financial pressures faced by organizations as they strive to integrate advanced AI technologies into their operations.
Moreover, fewer than 12% of surveyed pharmaceutical organizations have implemented formal drift detection mechanisms for their production clinical AI models. This lack of monitoring raises concerns about the reliability and accuracy of AI systems over time.
The average duration between deployment and database lock for Phase 3 programs stands at 28 months, emphasizing the need for timely updates and oversight in AI applications.
Organizations that have deployed feature stores report a median 43% reduction in duplicated feature engineering efforts across model teams, showcasing the efficiency gains possible through structured data management.
The FDA’s proposed Predetermined Change Control Plan framework envisions pre-approved protocols for updating AI models in production, which could significantly enhance operational reliability.
As MLOps continues to evolve, its principles are increasingly applied to AI, stressing the importance of infrastructure for deploying, updating, and monitoring AI models effectively.
The productive deployment of AI in clinical data operations is contingent on the maturation of MLOps infrastructure. Without continuous monitoring and drift detection, models degrade invisibly, leading to a widening gap between the potential value of clinical AI and its realized operational contribution.
As the workshop approaches, experts emphasize the critical question: will the AI deployed by organizations remain accurate, reliable, and defensible two years after its initial deployment?
First reactions to the workshop have been positive, with many expressing optimism about the potential for improved skills and knowledge in the rapidly evolving field of deep learning.
Details remain unconfirmed regarding the specific speakers and agenda for the workshop, but it is expected to attract a diverse group of participants eager to enhance their understanding of machine learning applications.
